2025 ESUR Prostate Pathway
ESUR Mtg - Stockholm 2025 Learning objectives: To provide an update on the performance of PI-RADS v2.1 for early detection. To differentiate between MRI-alone and integrated risk-based pathways. To outline the prerequisites for any MRI-based diagnostic pathway. To discuss new methods for assessing the clinical benefits and harms of the MRI pathway in the context of biopsy avoidance.
▶︎
Prostate MRIs in 2025 | #MarkScholzMD #AlexScholz #PCRI #ProstateCancer
▶︎
Risk Pathway ESUR 2025 Narration
▶︎
The Power Of Exercise For Prostate Cancer | Robert Newton, PHD & Q+A with Mark Moyad, MD #PCRI
▶︎
AI for Prostate Cancer Screening; future perspecives
▶︎
Advanced Prostate Cancer in the News 2026: A Case-Based Multidisciplinary Update (2026)
▶︎
PI-RADS Explained: What Your Prostate MRI Result Really Means
▶︎
PSA Too High? 6 Foods to Avoid Before a PSA Test
▶︎
Is Prostate Artery Embolization Right for You? | BPH Treatment ft. Dr. Aaron Fischman
▶︎
Understanding Prostate Biopsy Results | #MarkScholzMD #AlexScholz #PCRI
▶︎
Challenges for MRI in Screening 2025: a NoteBookLM disussion
▶︎
Stop Blind Biopsies: Near-Perfect Prostate Cancer Accuracy with Dr. Mark Emberton - EP 170
▶︎
Prostate Biopsy: Why You Might Regret Getting One—and What to Do If You Already Did | Dr. Petteruti
▶︎
Prostate Cancer: The ABCs of Androgen Deprivation Therapy
▶︎
When Is Radiotherapy Right for Prostate Cancer?
▶︎
Managing an Elevated PSA: Avoiding Unnecessary Prostate Biopsies
▶︎
ECR 2025: Deep Learning Reconstruction in Prostate MRI
▶︎
Prostate Cancer Unveiled: Innovations in Diagnosis & Treatment
▶︎
Risk of Metastasis if you DON'T Treat Prostate Cancer
▶︎
How a Pathologist for Prostate Cancer Reads a biopsy & Cribriform with Dr. Jonathan Epstein –178
▶︎